SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-18-323752
Filing Date
2018-11-09
Accepted
2018-11-09 16:03:51
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-1/A d617454ds1a.htm S-1/A 2332878
2 EX-10.7.2 d617454dex1072.htm EX-10.7.2 22919
3 EX-23.1 d617454dex231.htm EX-23.1 1848
4 GRAPHIC g617454g00t08.jpg GRAPHIC 90099
5 GRAPHIC g617454g02l10.jpg GRAPHIC 108493
6 GRAPHIC g617454g26k67.jpg GRAPHIC 61928
7 GRAPHIC g617454g35i21.jpg GRAPHIC 149024
8 GRAPHIC g617454g46h29.jpg GRAPHIC 58964
9 GRAPHIC g617454g55e09.jpg GRAPHIC 190872
10 GRAPHIC g617454g68r45.jpg GRAPHIC 131059
11 GRAPHIC g617454g84b16.jpg GRAPHIC 74453
  Complete submission text file 0001193125-18-323752.txt   3549948
Mailing Address 509 S. EXETER ST., SUITE 202 BALTIMORE MD 21202
Business Address 509 S. EXETER ST., SUITE 202 BALTIMORE MD 21202 212-956-1111
Centrexion Therapeutics Corp (Filer) CIK: 0001592052 (see all company filings)

IRS No.: 320402377 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-227902 | Film No.: 181173086
SIC: 2834 Pharmaceutical Preparations